HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway.

Abstract
An abnormal high mobility group box 1 (HMGB1) activation and a decrease in receptor for advanced glycation end-product (RAGE) play a key role in the pathogenesis of pulmonary fibrosis. Protocatechuic aldehyde (PA) is a naturally occurring compound, which is extracted from the degradation of phenolic acids. However, whether PA has anti-fibrotic functions is unknown. In this study, the effects of PA on the transforming growth factor-β1 (TGF-β1)-mediated epithelial-mesenchymal transition (EMT) in A549 cells, on the apoptosis of human type I alveolar epithelial cells (AT I), on the proliferation of human lung fibroblasts (HLF-1) in vitro, and on bleomycin (BLM)-induced pulmonary fibrosis in vivo were investigated. PA treatment resulted in a reduction of EMT in A549 cells with a decrease in vimentin and HMGB, an increase of E-cadherin and RAGE, a reduction of HLF-1 proliferation with a decrease of fibroblast growth factor 2 (FGF-2) and platelet-derived growth factor (PDGF). Apoptosis of AT I was attenuated with an increase of RAGE. PA ameliorated BLM-induced pulmonary fibrosis in rats with a reduction of histopathological scores and collagen deposition, and a lower FGF-2, PDGF, α-smooth muscle actin (α-SMA) and HMGB1 expression, whereas higher RAGE was found in BLM-instilled lungs. Through the decrease of HGMB1 and the regulation of RAGE, PA reversed the EMT, inhibited HLF-1 proliferation as well as reduced apoptosis in AT I, and prevented pulmonary fibrosis in vivo. Collectively, our results demonstrate that PA prevents experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway.
AuthorsLiang Zhang, Yunxia Ji, Zechun Kang, Changjun Lv, Wanglin Jiang
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 283 Issue 1 Pg. 50-6 (Feb 15 2015) ISSN: 1096-0333 [Electronic] United States
PMID25582705 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Actins
  • Benzaldehydes
  • Catechols
  • HMGB1 Protein
  • HMGB1 protein, human
  • Hbp1 protein, rat
  • Platelet-Derived Growth Factor
  • RNA, Small Interfering
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
  • Transforming Growth Factor beta1
  • smooth muscle actin, rat
  • Fibroblast Growth Factor 2
  • Bleomycin
  • protocatechualdehyde
  • Collagen
Topics
  • Actins (metabolism)
  • Animals
  • Apoptosis (drug effects)
  • Benzaldehydes (pharmacology, therapeutic use)
  • Bleomycin
  • Catechols (pharmacology, therapeutic use)
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Collagen (metabolism)
  • Epithelial-Mesenchymal Transition (drug effects)
  • Fibroblast Growth Factor 2 (metabolism)
  • HMGB1 Protein (genetics, metabolism)
  • Humans
  • Lung (drug effects, metabolism, pathology)
  • Male
  • Platelet-Derived Growth Factor (metabolism)
  • Pulmonary Fibrosis (chemically induced, drug therapy, metabolism, pathology)
  • RNA, Small Interfering (genetics)
  • Rats, Sprague-Dawley
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic (metabolism)
  • Signal Transduction
  • Transforming Growth Factor beta1 (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: